Preservation of cochlear function in Cd39 deficient mice

被引:3
|
作者
Vlajkovic, Srdjan M. [1 ]
Housley, Gary D. [1 ]
Thorne, Peter R. [1 ,2 ]
Gupta, Rita [1 ]
Enjyoji, Keiichi [3 ]
Cowan, Peter J. [4 ,5 ]
Liberman, M. Charles [6 ]
Robson, Simon C. [3 ]
机构
[1] Univ Auckland, Fac Med & Hlth Sci, Dept Physiol, Auckland 1142, New Zealand
[2] Univ Auckland, Fac Med & Hlth Sci, Discipline Audiol, Auckland 1142, New Zealand
[3] Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Univ Melbourne, St Vincents Hosp Melbourne, Immunol Res Ctr, Melbourne, Vic, Australia
[5] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[6] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA
关键词
CD39; NTPDase1; Ectonucleotidase; Purinergic signalling; Knockout mice; Hearing; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE-1; UP-REGULATION; CATALYTIC PROPERTIES; ECTONUCLEOTIDASES; PROTECTION; EXPRESSION; ADENOSINE; NTPDASE1; CELLS; IDENTIFICATION;
D O I
10.1016/j.heares.2009.03.009
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Signalling actions of extracellular nucleotides via P2 receptors influence cellular function in most tissues. In the inner ear, P2 receptor signaling is involved in many processes including the regulation of hearing sensitivity and the cochlea's response to noise stress. CD39 (NTPDase1/ENTPD1) is an ectonucleotidase (ecto-nucleoside triphosphate diphosphohydrolase) that can hydrolyse purine and pyrimidine nucleoside tri- and di-phosphates to generate monophosphate nucleosides. Mice null for Cd39 exhibit major alterations in haemostasis and profound alterations in inflammatory and thrombotic reactions. Studies in the cochlea have suggested the involvement of purinergic-type signals that could be modulated by CD39 in regulation of cochlear blood flow and also auditory neurotransmission. This study aimed to determine the auditory phenotype of adult Cd39 null mice on the C57BL6 background. Auditory brainstem responses (ABR) and distortion product otoacoustic emissions (DPOAE) were unaffected in Cd39-deficient mice across the range of test frequencies, suggesting normal neural and outer hair cell function. Mutant mice also showed little difference to wild type mice in vulnerability to acoustic trauma. Gene expression analysis of other membrane-bound NTPDases with comparable hydrolytic activity demonstrated an up-regulation of Entpd2 and Entpd8 in the cochleae of Cd39 deficient mice. These findings suggest that Cd39 deletion alone does not adversely affect cochlear function, possibly as compensatory up-regulation of other surface located NTPDases may offset predicted alterations in cochlear homeostasis. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 50 条
  • [41] Functional reconstitution of CD39 into phospholipid vesicles
    Haller, C
    Cui, WX
    Robson, SC
    Chaikof, EL
    CIRCULATION, 2004, 110 (17) : 215 - 215
  • [42] Vascular ATP diphosphohydrolase (CD39/ATPDase)
    Kaczmarek, E
    Siegel, JB
    Sevigny, J
    Koziak, K
    Hancock, WW
    Beaudoin, A
    Bach, FH
    Robson, SC
    ECTO-ATPASES: RECENT PROGRESS ON STRUCTURE AND FUNCTION, 1997, : 171 - 185
  • [43] Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation
    Dwyer, KM
    Robson, SC
    Nandurkar, HH
    Campbell, DJ
    Gock, H
    Murray-Segal, LJ
    Fisicaro, N
    Mysore, TB
    Kaczmarek, E
    Cowan, PJ
    d'Apice, AJF
    JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (10): : 1440 - 1446
  • [44] CD39的研究进展
    席娜娜
    王潭
    郑荣远
    现代免疫学, 2010, 30 (02) : 168 - 171
  • [45] CD39 Expression in Mesenchymal Stromal Cells
    Saldanha-Araujo, Felipe
    Panepucci, Rodrigo A.
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (07) : 568 - 568
  • [46] CD39 and control of cellular immune responses
    Karen M. Dwyer
    Silvia Deaglio
    Wenda Gao
    David Friedman
    Terry B. Strom
    Simon C. Robson
    Purinergic Signalling, 2007, 3 : 171 - 180
  • [47] Lower risk of cardiac rupture in CD39 null mice post myocardial infarction
    Ogawa, M
    Ogawa, N
    Nakayama, M
    Csizmadia, E
    Enjyoji, K
    Kohzuki, M
    Robson, SC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 205A - 205A
  • [48] CD39 as a caveolar-associated ectonucleotidase
    Kittel, A
    Kaczmarek, E
    Sevigny, J
    Lengyel, K
    Csizmadia, E
    Robson, SC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 262 (03) : 596 - 599
  • [49] Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors
    Schaekel, Laura
    Schmies, Constanze C.
    Idris, Riham M.
    Luo, Xihuan
    Lee, Sang-Yong
    Lopez, Vittoria
    Mirza, Salahuddin
    Vu, The Hung
    Pelletier, Julie
    Sevigny, Jean
    Namasivayam, Vigneshwaran
    Mueller, Christa E.
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [50] Leukoregulatory role of CD39 in ischemic vessels
    Fujita, T
    Maliszewski, CR
    Liao, H
    Okada, K
    Marcus, AJ
    Broekman, MJ
    Ramasamy, R
    Pinsky, DJ
    CIRCULATION, 2001, 104 (17) : 274 - 274